Semaxin
Extended-release formulation and variant of Semax — developed for enhanced nootropic and neuroprotective applications with improved pharmacokinetic profile.
🔬 Mechanism of Action
Semaxin is an enhanced formulation variant of Semax — the ACTH(4-10) heptapeptide nootropic approved in Russia for stroke, TBI, and cognitive enhancement. Semaxin incorporates pharmacokinetic modifications to extend the duration of action compared to standard Semax.
The core mechanism is shared with Semax: binding to melanocortin receptors (MC3R, MC4R) in the CNS triggers upregulation of BDNF and NGF — the two most important neurotrophic factors for synaptic plasticity, neuronal survival, and learning/memory. Additionally, Semaxin modulates dopaminergic and serotonergic neurotransmission, improving mood, focus, and executive function.
Intranasal delivery ensures direct CNS penetration via olfactory neurons bypassing the blood-brain barrier — making it one of the most bioavailable nootropic peptides available.
Source: Based on PMID: 17436040
📜Background & History
Semaxin is an enhanced formulation variant of the ACTH(4-10) fragment Semax, featuring pharmacokinetic modifications for extended duration. Semax itself was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and approved in Russia for medical use since 1994 for stroke, optic nerve disease, and cognitive enhancement. Semaxin builds on this 30+ year clinical foundation with improved delivery characteristics.
🎯 Research Use Cases
- ✓Sustained nootropic cognitive enhancement
- ✓Extended neuroprotection in post-stroke recovery
- ✓Focus and executive function improvement
- ✓BDNF/NGF upregulation with longer duration vs standard Semax
💉 Dosing Protocol
| Typical Dose | 200-600 mcg/day (intranasal) |
| Frequency | 1-2× daily |
| Half-Life | ~2-4 hours |
| Common Vial Sizes | 3 mg, 5 mg |
🧪 Reconstitution Example
⚠️Safety & Considerations
Based on the well-established Semax safety profile (30+ years Russian clinical use). Intranasal administration preferred. Avoid in active epilepsy (theoretical seizure threshold lowering from CNS stimulation). No dependence or tolerance documented. Safe for long-term use at recommended doses.
⚡Interactions & Contraindications
Intranasal delivery preferred for CNS penetration. Avoid in active epilepsy (theoretical seizure threshold lowering). No dependence or tolerance documented. Compatible with most nootropic protocols.
🔗Synergies & Common Stacks
The classic Russian peptide stack: Semaxin (nootropic/dopaminergic) + NASA (anxiolytic/GABAergic) — comprehensive cognitive-emotional optimization with complementary mechanisms.
Semaxin for daytime cognitive enhancement + Pinealon for evening/sleep support → 24-hour neurological optimization cycle.